BioXcel Therapeutics, Inc.

/BioXcel Therapeutics, Inc.

They are a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.


Price Range
$11.00 - $13.00

Final Shares

Effective Date
March 8, 2018


To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange